Avanos Medical, Inc. (NYSE:AVNS) Shares Purchased by Bridgeway Capital Management LLC

Bridgeway Capital Management LLC boosted its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 87.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 273,251 shares of the company's stock after purchasing an additional 127,591 shares during the period. Bridgeway Capital Management LLC owned about 0.59% of Avanos Medical worth $4,350,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of AVNS. Barclays PLC boosted its stake in shares of Avanos Medical by 446.2% during the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock worth $2,311,000 after acquiring an additional 78,583 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Avanos Medical by 6.9% in the third quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company's stock worth $1,672,000 after purchasing an additional 4,472 shares during the last quarter. Tributary Capital Management LLC increased its stake in Avanos Medical by 38.1% in the 4th quarter. Tributary Capital Management LLC now owns 893,008 shares of the company's stock worth $14,217,000 after acquiring an additional 246,379 shares during the last quarter. Empowered Funds LLC increased its position in Avanos Medical by 141.3% in the fourth quarter. Empowered Funds LLC now owns 153,834 shares of the company's stock worth $2,449,000 after purchasing an additional 90,091 shares during the last quarter. Finally, New York State Teachers Retirement System raised its position in shares of Avanos Medical by 4.0% during the 4th quarter. New York State Teachers Retirement System now owns 75,215 shares of the company's stock valued at $1,197,000 after buying an additional 2,921 shares in the last quarter. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, StockNews.com upgraded Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Avanos Medical Trading Up 0.6 %

AVNS stock traded up $0.07 during midday trading on Friday, reaching $12.65. The company's stock had a trading volume of 406,766 shares, compared to its average volume of 348,361. The stock has a fifty day simple moving average of $13.43 and a two-hundred day simple moving average of $16.03. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The firm has a market capitalization of $581.94 million, a price-to-earnings ratio of 37.21 and a beta of 1.13. Avanos Medical, Inc. has a 1 year low of $11.84 and a 1 year high of $25.36.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.19 by $0.07. The company had revenue of $167.50 million for the quarter, compared to the consensus estimate of $161.75 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Avanos Medical's quarterly revenue was up .8% on a year-over-year basis. During the same period last year, the business posted $0.22 EPS. On average, equities research analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Insider Activity at Avanos Medical

In related news, SVP Kerr Holbrook sold 7,000 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the transaction, the senior vice president now owns 82,047 shares in the company, valued at $1,251,216.75. The trade was a 7.86 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.64% of the stock is currently owned by corporate insiders.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.